{"entity":{"type":"insider","cik":"0001601576","url":"/insider/0001601576","json_url":"/insider/0001601576.json","name":"Bendheim Daniel M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":10,"first":"2017-08-16","last":"2019-01-30","span_basis":"filed_date"},"name_variants":[{"name":"Bendheim Daniel M","source":"filing","n_filings":10,"first_seen":"2017-08-16","last_seen":"2019-01-30"}],"transactions":[{"id":7954013,"accession":"0001144204-19-003872","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-19-003872","line_url":"/filing/0001144204-19-003872#line-6","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2390.0,"shares_display":"2,390","price_per_share":31.15,"price_display":"31.15","price_state":"stated","total_value":74448.5,"total_display":"74,448.50","total_whole":"74,449","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-30","filed_date":"2019-01-30","scope":"insider"},{"id":7954009,"accession":"0001144204-19-003872","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-19-003872","line_url":"/filing/0001144204-19-003872#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4890.0,"shares_display":"4,890","price_per_share":31.32,"price_display":"31.32","price_state":"stated","total_value":153154.8,"total_display":"153,154.80","total_whole":"153,155","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-29","filed_date":"2019-01-30","scope":"insider"},{"id":7954005,"accession":"0001144204-19-003872","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-003872","line_url":"/filing/0001144204-19-003872#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.55,"price_display":"31.55","price_state":"stated","total_value":78875.0,"total_display":"78,875.00","total_whole":"78,875","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-28","filed_date":"2019-01-30","scope":"insider"},{"id":8447864,"accession":"0001144204-19-002703","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001144204-19-002703","line_url":"/filing/0001144204-19-002703#line-7","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.78,"price_display":"31.78","price_state":"stated","total_value":79450.0,"total_display":"79,450.00","total_whole":"79,450","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-24","filed_date":"2019-01-24","scope":"insider"},{"id":8447856,"accession":"0001144204-19-002703","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001144204-19-002703","line_url":"/filing/0001144204-19-002703","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.7216,"price_display":"31.72","price_state":"stated","total_value":79304.0,"total_display":"79,304.00","total_whole":"79,304","shares_owned_after":590.0,"shares_owned_after_display":"590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-23","filed_date":"2019-01-24","scope":"insider","n_lines":2},{"id":8447845,"accession":"0001144204-19-002703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-002703","line_url":"/filing/0001144204-19-002703#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.4,"price_display":"31.40","price_state":"stated","total_value":78500.0,"total_display":"78,500.00","total_whole":"78,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-22","filed_date":"2019-01-24","scope":"insider"},{"id":8641818,"accession":"0001144204-19-002146","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-19-002146","line_url":"/filing/0001144204-19-002146#line-6","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.04,"price_display":"32.04","price_state":"stated","total_value":80100.0,"total_display":"80,100.00","total_whole":"80,100","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-18","filed_date":"2019-01-18","scope":"insider"},{"id":8641814,"accession":"0001144204-19-002146","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-19-002146","line_url":"/filing/0001144204-19-002146#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.24,"price_display":"32.24","price_state":"stated","total_value":80600.0,"total_display":"80,600.00","total_whole":"80,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-17","filed_date":"2019-01-18","scope":"insider"},{"id":8641807,"accession":"0001144204-19-002146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-002146","line_url":"/filing/0001144204-19-002146#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.4,"price_display":"32.40","price_state":"stated","total_value":81000.0,"total_display":"81,000.00","total_whole":"81,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-18","scope":"insider"},{"id":7918188,"accession":"0001144204-19-001393","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-19-001393","line_url":"/filing/0001144204-19-001393#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.54,"price_display":"32.54","price_state":"stated","total_value":81350.0,"total_display":"81,350.00","total_whole":"81,350","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-09","filed_date":"2019-01-10","scope":"insider"},{"id":7918181,"accession":"0001144204-19-001393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-001393","line_url":"/filing/0001144204-19-001393#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.31,"price_display":"32.31","price_state":"stated","total_value":80775.0,"total_display":"80,775.00","total_whole":"80,775","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-10","scope":"insider"},{"id":8425257,"accession":"0001144204-19-000965","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-19-000965","line_url":"/filing/0001144204-19-000965#line-6","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.21,"price_display":"32.21","price_state":"stated","total_value":80525.0,"total_display":"80,525.00","total_whole":"80,525","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-07","scope":"insider"},{"id":8425251,"accession":"0001144204-19-000965","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-19-000965","line_url":"/filing/0001144204-19-000965#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.3,"price_display":"31.30","price_state":"stated","total_value":78250.0,"total_display":"78,250.00","total_whole":"78,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-07","scope":"insider"},{"id":8425245,"accession":"0001144204-19-000965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-19-000965","line_url":"/filing/0001144204-19-000965#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.72,"price_display":"31.72","price_state":"stated","total_value":79300.0,"total_display":"79,300.00","total_whole":"79,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-07","scope":"insider"},{"id":6135477,"accession":"0001144204-18-049580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-049580","line_url":"/filing/0001144204-18-049580#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":44.3,"price_display":"44.30","price_state":"stated","total_value":110750.0,"total_display":"110,750.00","total_whole":"110,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-12","filed_date":"2018-09-14","scope":"insider"},{"id":6098587,"accession":"0001144204-18-014217","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-18-014217","line_url":"/filing/0001144204-18-014217#line-6","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13162.0,"shares_display":"13,162","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":526480.0,"total_display":"526,480.00","total_whole":"526,480","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-12","scope":"insider"},{"id":6098581,"accession":"0001144204-18-014217","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-18-014217","line_url":"/filing/0001144204-18-014217#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6576.0,"shares_display":"6,576","price_per_share":40.03,"price_display":"40.03","price_state":"stated","total_value":263237.28,"total_display":"263,237.28","total_whole":"263,237","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-03-12","scope":"insider"},{"id":6098576,"accession":"0001144204-18-014217","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-014217","line_url":"/filing/0001144204-18-014217#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3425.0,"shares_display":"3,425","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":137000.0,"total_display":"137,000.00","total_whole":"137,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-08","filed_date":"2018-03-12","scope":"insider"},{"id":6098554,"accession":"0001144204-18-013456","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-18-013456","line_url":"/filing/0001144204-18-013456#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":40.15,"price_display":"40.15","price_state":"stated","total_value":4015.0,"total_display":"4,015.00","total_whole":"4,015","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-07","scope":"insider"},{"id":6098548,"accession":"0001144204-18-013456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-18-013456","line_url":"/filing/0001144204-18-013456#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3860.0,"shares_display":"3,860","price_per_share":40.06,"price_display":"40.06","price_state":"stated","total_value":154631.6,"total_display":"154,631.60","total_whole":"154,632","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-07","scope":"insider"},{"id":5075525,"accession":"0001144204-17-044479","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-17-044479","line_url":"/filing/0001144204-17-044479#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":40.02,"price_display":"40.02","price_state":"stated","total_value":32016.0,"total_display":"32,016.00","total_whole":"32,016","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-21","filed_date":"2017-08-21","scope":"insider"},{"id":5075518,"accession":"0001144204-17-044479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-044479","line_url":"/filing/0001144204-17-044479#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4176.0,"shares_display":"4,176","price_per_share":40.01,"price_display":"40.01","price_state":"stated","total_value":167081.76,"total_display":"167,081.76","total_whole":"167,082","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-17","filed_date":"2017-08-21","scope":"insider"},{"id":4287338,"accession":"0001144204-17-043763","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001144204-17-043763","line_url":"/filing/0001144204-17-043763#line-6","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5938.0,"shares_display":"5,938","price_per_share":40.04,"price_display":"40.04","price_state":"stated","total_value":237757.52,"total_display":"237,757.52","total_whole":"237,758","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-16","filed_date":"2017-08-16","scope":"insider"},{"id":4287332,"accession":"0001144204-17-043763","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-17-043763","line_url":"/filing/0001144204-17-043763#line-4","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1443.0,"shares_display":"1,443","price_per_share":40.05,"price_display":"40.05","price_state":"stated","total_value":57792.15,"total_display":"57,792.15","total_whole":"57,792","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-16","scope":"insider"},{"id":4287324,"accession":"0001144204-17-043763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-043763","line_url":"/filing/0001144204-17-043763#line-2","is_derivative":false,"issuer_cik":"0001069899","issuer_name":"PHIBRO ANIMAL HEALTH CORP","issuer_ticker":"PAHC","issuer_name_source":null,"issuer_url":"/issuer/0001069899","owner_cik":"0001601576","owner_name":"Bendheim Daniel M","owner_display_name":"Bendheim Daniel M","owner_url":"/insider/0001601576","role":"Director, Officer (Exec. VP, Corporate Strategy)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP, Corporate Strategy","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":40.08,"price_display":"40.08","price_state":"stated","total_value":12024.0,"total_display":"12,024.00","total_whole":"12,024","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001069899","name":"PHIBRO ANIMAL HEALTH CORP","url":"/issuer/0001069899","role":"Director, Officer (Exec. VP, Corporate Strategy)","n_filings":10,"first_seen":"2017-08-16","last_seen":"2019-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001601576","retrieved_at":"2026-08-22T08:04:37+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}